+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Non-invasive Prenatal Genetic Testing Market - Global Forecast 2026-2032- Product Image
Non-invasive Prenatal Genetic Testing Market - Global Forecast 2026-2032- Product Image
Sale

Non-invasive Prenatal Genetic Testing Market - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6154765
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Non-invasive Prenatal Genetic Testing Market is projected to reach USD 284.14 Million in 2026. It is expected to continue growing at a CAGR of 7.21%, reaching USD 431.00 Million by 2032.

Non-invasive Prenatal Genetic Testing: Executive Overview

Non-invasive prenatal genetic testing (NIPT) analyzes cell-free fetal DNA in maternal blood to screen for selected chromosomal abnormalities, most commonly trisomies 21, 18, and 13. It is a screening test rather than a diagnostic procedure, so positive or clinically concerning results require genetic counseling and confirmatory diagnostic testing. Adoption is shaped by clinical guidelines, laboratory quality, reimbursement, informed consent, and access to follow-up care.

Clinical Integration Is Reshaping Prenatal Screening

The landscape is shifting from isolated testing toward integrated prenatal-care pathways that combine risk assessment, ultrasound, genetic counseling, laboratory analysis, and confirmatory procedures. Greater attention to test performance across different fetal fractions, gestational ages, twin pregnancies, and other complex pregnancies is encouraging more standardized protocols. Ethical governance, transparent reporting of limitations, and equitable access are increasingly important as screening becomes more routine.

Artificial Intelligence Improves Interpretation, Workflow, and Quality Control

Artificial intelligence can support laboratory workflow, sequencing-quality assessment, signal interpretation, variant prioritization, and identification of samples requiring review. It may also help clinicians combine screening results with maternal characteristics, ultrasound findings, and pregnancy history. However, AI outputs require clinical validation, monitoring for population-specific bias, explainability, cybersecurity safeguards, and human oversight. AI does not convert a screening result into a diagnosis and cannot replace counseling or confirmatory testing.

Regional Insights: Access and Regulation Remain Uneven

North America is characterized by established laboratory infrastructure, specialist services, and ongoing debates over reimbursement and appropriate use. Europe combines advanced prenatal-care systems with country-level differences in reimbursement, consent, and regulation. Asia-Pacific includes technologically advanced health systems alongside substantial variation in access between urban and rural settings. Latin America is expanding laboratory and clinical capacity while facing affordability and geographic-access barriers. The Middle East is influenced by specialized private-care networks, national screening priorities, and culturally informed counseling. Africa shows significant unmet need associated with limited laboratory capacity, specialist availability, and referral infrastructure, although regional centers are strengthening capability.

Group Insights: Multilateral and Economic Blocs Shape Implementation

ASEAN members face varied healthcare financing, laboratory capacity, and cross-border referral conditions, making harmonized training and quality standards valuable. BRICS countries reflect wide differences in population scale, public-sector capacity, regulation, and access to genetic counseling. The European Union benefits from shared scientific and regulatory frameworks while retaining national differences in reimbursement and service delivery. G7 health systems generally have mature prenatal-care infrastructure but continue to address affordability, informed consent, and equitable access. GCC countries often combine advanced specialist facilities with centralized health planning and a strong role for private care. NATO members span diverse healthcare models, making interoperability and evidence-based clinical standards more relevant than defense alignment itself.

Country Insights: National Care Models Drive Use and Oversight

Australia and Canada emphasize publicly guided prenatal care while managing geographic access and referral distances. The United States has broad laboratory availability but variable insurance coverage, state-level policy environments, and counseling access. Brazil and Mexico are expanding capabilities amid uneven public-private access and regional disparities. China, India, Japan, and South Korea combine advanced urban services with differing reimbursement, regulatory, and counseling structures. France, Germany, Italy, Spain, and the United Kingdom operate within comparatively developed prenatal-care systems, but national guidance, funding pathways, and consent practices differ. Russia’s provision is shaped by regional healthcare variation, laboratory access, and evolving clinical governance.

Action Priorities for Leaders: Build Trusted, Equitable Testing Pathways

Industry leaders should validate assays across clinically relevant pregnancy types and ancestry groups, publish clear performance and failure-rate data, and maintain robust laboratory quality systems. They should pair testing with accessible genetic counseling, defined referral pathways, and confirmatory-diagnostic support. Providers and policymakers can improve trust through standardized consent materials, transparent communication that distinguishes screening from diagnosis, and privacy protections for genomic data. Responsible AI deployment should include independent validation, bias monitoring, audit trails, and clinician accountability. Expanding regional partnerships, workforce training, and sample logistics can help reduce geographic and socioeconomic gaps.

Research Methodology: Evidence-Led Assessment of the Testing Ecosystem

This executive summary uses a structured qualitative assessment of non-invasive prenatal genetic testing, focusing on clinical application, technology, regulation, healthcare infrastructure, access, and implementation conditions. The analysis organizes evidence by the required regions, economic and political groups, and countries, while distinguishing screening from diagnostic use. It excludes market estimates, market sizing, market shares, forecasts, and company-specific claims. Interpretation should be refreshed as clinical guidelines, reimbursement policies, laboratory standards, and peer-reviewed evidence evolve.

Conclusion: Responsible Integration Will Determine Long-Term Value

Non-invasive prenatal genetic testing is becoming an important component of contemporary prenatal screening, but its clinical value depends on more than analytical performance. Reliable implementation requires appropriate patient selection, informed consent, skilled counseling, confirmatory testing, equitable access, and strong quality oversight. Regions and countries will progress at different speeds as they adapt regulation, reimbursement, infrastructure, and workforce capacity. Leaders that prioritize evidence, transparency, and responsible technology integration will be better positioned to support safe and patient-centered prenatal care.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Non-invasive Prenatal Genetic Testing Market, by Product Type
7.1. Introduction
7.2. Reagent Kits
7.3. Services
8. Non-invasive Prenatal Genetic Testing Market, by Technology
8.1. Introduction
8.2. Microarray
8.2.1. Cgh Array
8.2.2. Snp Array
8.3. Ngs
8.3.1. Targeted Ngs
8.3.2. Whole Genome Ngs
8.4. Qpcr
9. Non-invasive Prenatal Genetic Testing Market, by Testing Approach
9.1. Introduction
9.2. Genome Wide
9.3. Targeted
10. Non-invasive Prenatal Genetic Testing Market, by Indication
10.1. Introduction
10.2. Down Syndrome
10.3. Sex Chromosome Aneuploidies
10.4. Trisomy 13
10.5. Trisomy 18
11. Non-invasive Prenatal Genetic Testing Market, by End User
11.1. Introduction
11.2. Diagnostic Centers
11.3. Hospital Labs
11.4. Research Labs
12. Non-invasive Prenatal Genetic Testing Market, by Application
12.1. Introduction
12.2. Expanded Panels
12.2.1. Microdeletion Panels
12.2.2. Microduplication Panels
12.3. High Risk Pregnancies
12.3.1. Advanced Maternal Age
12.3.2. Family History
12.4. Routine Screening
12.4.1. First Trimester
12.4.2. Second Trimester
12.5. Twin Pregnancies
13. Non-invasive Prenatal Genetic Testing Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Non-invasive Prenatal Genetic Testing Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Non-invasive Prenatal Genetic Testing Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. BGI Genomics Co., Ltd.
17.2. Centogene AG
17.3. Circle Genetics, Inc.
17.4. DNA Diagnostics Center, Inc.
17.5. Fulgent Genetics, Inc.
17.6. GenPath, Inc.
17.7. Illumina, Inc.
17.8. Laboratory Corporation of America Holdings
17.9. LifeLabs Medical Laboratory Services
17.10. Medgenome Labs, Inc.
17.11. Myriad Genetics, Inc.
17.12. Natera, Inc.
17.13. PerkinElmer, Inc.
17.14. Premaitha Health plc
17.15. Quest Diagnostics Incorporated
17.16. Roche Diagnostics International Ltd.
17.17. Sema4, Inc.
17.18. Trinity Biotech plc
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Non-invasive Prenatal Genetic Testing Market, Years Considered for the Study
FIGURE 2. Global Non-invasive Prenatal Genetic Testing Market, Research Design
FIGURE 3. Global Non-invasive Prenatal Genetic Testing Market, Research Framework
FIGURE 4. Global Non-invasive Prenatal Genetic Testing Market, Data Triangulation
FIGURE 5. Global Non-invasive Prenatal Genetic Testing Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Non-invasive Prenatal Genetic Testing Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Non-invasive Prenatal Genetic Testing Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Non-invasive Prenatal Genetic Testing Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Non-invasive Prenatal Genetic Testing Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Non-invasive Prenatal Genetic Testing Market Size, by Testing Approach, 2025 vs 2032 (%)
FIGURE 11. Global Non-invasive Prenatal Genetic Testing Market Size, by Testing Approach, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Non-invasive Prenatal Genetic Testing Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 13. Global Non-invasive Prenatal Genetic Testing Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Non-invasive Prenatal Genetic Testing Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Non-invasive Prenatal Genetic Testing Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Non-invasive Prenatal Genetic Testing Market Size, by Application, 2025 vs 2032 (%)
FIGURE 17. Global Non-invasive Prenatal Genetic Testing Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Non-invasive Prenatal Genetic Testing Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Non-invasive Prenatal Genetic Testing Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Non-invasive Prenatal Genetic Testing Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Non-invasive Prenatal Genetic Testing Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Non-invasive Prenatal Genetic Testing Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Non-invasive Prenatal Genetic Testing Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Non-invasive Prenatal Genetic Testing Market Segmentation & Coverage
TABLE 2. Global Non-invasive Prenatal Genetic Testing Market Size, 2017-2032 (USD Million)
TABLE 3. Global Non-invasive Prenatal Genetic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Reagent Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Reagent Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Reagent Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Non-invasive Prenatal Genetic Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 11. Global Microarray Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Microarray Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Microarray Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Cgh Array Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Cgh Array Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Cgh Array Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Snp Array Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Snp Array Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Snp Array Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Ngs Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Ngs Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Ngs Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Targeted Ngs Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Targeted Ngs Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Targeted Ngs Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Whole Genome Ngs Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Whole Genome Ngs Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Whole Genome Ngs Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Qpcr Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Qpcr Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Qpcr Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Non-invasive Prenatal Genetic Testing Market Size, by Testing Approach, 2017-2032 (USD Million)
TABLE 33. Global Genome Wide Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Genome Wide Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Genome Wide Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Targeted Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Targeted Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Targeted Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Non-invasive Prenatal Genetic Testing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 40. Global Down Syndrome Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Down Syndrome Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Down Syndrome Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Sex Chromosome Aneuploidies Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Sex Chromosome Aneuploidies Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Sex Chromosome Aneuploidies Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Trisomy 13 Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Trisomy 13 Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Trisomy 13 Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Trisomy 18 Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Trisomy 18 Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Trisomy 18 Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Non-invasive Prenatal Genetic Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 53. Global Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Hospital Labs Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Hospital Labs Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Hospital Labs Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Research Labs Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Research Labs Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Research Labs Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Non-invasive Prenatal Genetic Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 63. Global Expanded Panels Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Expanded Panels Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Expanded Panels Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Microdeletion Panels Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Microdeletion Panels Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Microdeletion Panels Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Microduplication Panels Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Microduplication Panels Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Microduplication Panels Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global High Risk Pregnancies Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global High Risk Pregnancies Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global High Risk Pregnancies Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Advanced Maternal Age Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Advanced Maternal Age Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Advanced Maternal Age Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Family History Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Family History Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Family History Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Routine Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Routine Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Routine Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global First Trimester Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global First Trimester Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global First Trimester Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Second Trimester Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Second Trimester Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Second Trimester Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Twin Pregnancies Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Twin Pregnancies Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Twin Pregnancies Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Non-invasive Prenatal Genetic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size, by Ngs, 2017-2032 (USD Million)
TABLE 99. Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size, by Testing Approach, 2017-2032 (USD Million)
TABLE 100. Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 103. Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size, by Expanded Panels, 2017-2032 (USD Million)
TABLE 104. Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size, by High Risk Pregnancies, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size, by Routine Screening, 2017-2032 (USD Million)
TABLE 106. North America Non-invasive Prenatal Genetic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. North America Non-invasive Prenatal Genetic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 108. North America Non-invasive Prenatal Genetic Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 109. North America Non-invasive Prenatal Genetic Testing Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 110. North America Non-invasive Prenatal Genetic Testing Market Size, by Ngs, 2017-2032 (USD Million)
TABLE 111. North America Non-invasive Prenatal Genetic Testing Market Size, by Testing Approach, 2017-2032 (USD Million)
TABLE 112. North America Non-invasive Prenatal Genetic Testing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 113. North America Non-invasive Prenatal Genetic Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. North America Non-invasive Prenatal Genetic Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 115. North America Non-invasive Prenatal Genetic Testing Market Size, by Expanded Panels, 2017-2032 (USD Million)
TABLE 116. North America Non-invasive Prenatal Genetic Testing Market Size, by High Risk Pregnancies, 2017-2032 (USD Million)
TABLE 117. North America Non-invasive Prenatal Genetic Testing Market Size, by Routine Screening, 2017-2032 (USD Million)
TABLE 118. Latin America Non-invasive Prenatal Genetic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Latin America Non-invasive Prenatal Genetic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 120. Latin America Non-invasive Prenatal Genetic Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 121. Latin America Non-invasive Prenatal Genetic Testing Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 122. Latin America Non-invasive Prenatal Genetic Testing Market Size, by Ngs, 2017-2032 (USD Million)
TABLE 123. Latin America Non-invasive Prenatal Genetic Testing Market Size, by Testing Approach, 2017-2032 (USD Million)
TABLE 124. Latin America Non-invasive Prenatal Genetic Testing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 125. Latin America Non-invasive Prenatal Genetic Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 126. Latin America Non-invasive Prenatal Genetic Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 127. Latin America Non-invasive Prenatal Genetic Testing Market Size, by Expanded Panels, 2017-2032 (USD Million)
TABLE 128. Latin America Non-invasive Prenatal Genetic Testing Market Size, by High Risk Pregnancies, 2017-2032 (USD Million)
TABLE 129. Latin America Non-invasive Prenatal Genetic Testing Market Size, by Routine Screening, 2017-2032 (USD Million)
TABLE 130. Europe Non-invasive Prenatal Genetic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Europe Non-invasive Prenatal Genetic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 132. Europe Non-invasive Prenatal Genetic Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 133. Europe Non-invasive Prenatal Genetic Testing Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 134. Europe Non-invasive Prenatal Genetic Testing Market Size, by Ngs, 2017-2032 (USD Million)
TABLE 135. Europe Non-invasive Prenatal Genetic Testing Market Size, by Testing Approach, 2017-2032 (USD Million)
TABLE 136. Europe Non-invasive Prenatal Genetic Testing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 137. Europe Non-invasive Prenatal Genetic Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 138. Europe Non-invasive Prenatal Genetic Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 139. Europe Non-invasive Prenatal Genetic Testing Market Size, by Expanded Panels, 2017-2032 (USD Million)
TABLE 140. Europe Non-invasive Prenatal Genetic Testing Market Size, by High Risk Pregnancies, 2017-2032 (USD Million)
TABLE 141. Europe Non-invasive Prenatal Genetic Testing Market Size, by Routine Screening, 2017-2032 (USD Million)
TABLE 142. Middle East Non-invasive Prenatal Genetic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Middle East Non-invasive Prenatal Genetic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 144. Middle East Non-invasive Prenatal Genetic Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 145. Middle East Non-invasive Prenatal Genetic Testing Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 146. Middle East Non-invasive Prenatal Genetic Testing Market Size, by Ngs, 2017-2032 (USD Million)
TABLE 147. Middle East Non-invasive Prenatal Genetic Testing Market Size, by Testing Approach, 2017-2032 (USD Million)
TABLE 148. Middle East Non-invasive Prenatal Genetic Testing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 149. Middle East Non-invasive Prenatal Genetic Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 150. Middle East Non-invasive Prenatal Genetic Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 151. Middle East Non-invasive Prenatal Genetic Testing Market Size, by Expanded Panels, 2017-2032 (USD Million)
TABLE 152. Middle East Non-invasive Prenatal Genetic Testing Market Size, by High Risk Pregnancies, 2017-2032 (USD Million)
TABLE 153. Middle East Non-invasive Prenatal Genetic Testing Market Size, by Routine Screening, 2017-2032 (USD Million)
TABLE 154. Africa Non-invasive Prenatal Genetic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 155. Africa Non-invasive Prenatal Genetic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 156. Africa Non-invasive Prenatal Genetic Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 157. Africa Non-invasive Prenatal Genetic Testing Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 158. Africa Non-invasive Prenatal Genetic Testing Market Size, by Ngs, 2017-2032 (USD Million)
TABLE 159. Africa Non-invasive Prenatal Genetic Testing Market Size, by Testing Approach, 2017-2032 (USD Million)
TABLE 160. Africa Non-invasive Prenatal Genetic Testing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 161. Africa Non-invasive Prenatal Genetic Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 162. Africa Non-invasive Prenatal Genetic Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 163. Africa Non-invasive Prenatal Genetic Testing Market Size, by Expanded Panels, 2017-2032 (USD Million)
TABLE 164. Africa Non-invasive Prenatal Genetic Testing Market Size, by High Risk Pregnancies, 2017-2032 (USD Million)
TABLE 165. Africa Non-invasive Prenatal Genetic Testing Market Size, by Routine Screening, 2017-2032 (USD Million)
TABLE 166. Global Non-invasive Prenatal Genetic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 167. ASEAN Non-invasive Prenatal Genetic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 168. ASEAN Non-invasive Prenatal Genetic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 169. ASEAN Non-invasive Prenatal Genetic Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 170. ASEAN Non-invasive Prenatal Genetic Testing Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 171. ASEAN Non-invasive Prenatal Genetic Testing Market Size, by Ngs, 2017-2032 (USD Million)
TABLE 172. ASEAN Non-invasive Prenatal Genetic Testing Market Size, by Testing Approach, 2017-2032 (USD Million)
TABLE 173. ASEAN Non-invasive Prenatal Genetic Testing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 174. ASEAN Non-invasive Prenatal Genetic Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. ASEAN Non-invasive Prenatal Genetic Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 176. ASEAN Non-invasive Prenatal Genetic Testing Market Size, by Expanded Panels, 2017-2032 (USD Million)
TABLE 177. ASEAN Non-invasive Prenatal Genetic Testing Market Size, by High Risk Pregnancies, 2017-2032 (USD Million)
TABLE 178. ASEAN Non-invasive Prenatal Genetic Testing Market Size, by Routine Screening, 2017-2032 (USD Million)
TABLE 179. GCC Non-invasive Prenatal Genetic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 180. GCC Non-invasive Prenatal Genetic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 181. GCC Non-invasive Prenatal Genetic Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 182. GCC Non-invasive Prenatal Genetic Testing Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 183. GCC Non-invasive Prenatal Genetic Testing Market Size, by Ngs, 2017-2032 (USD Million)
TABLE 184. GCC Non-invasive Prenatal Genetic Testing Market Size, by Testing Approach, 2017-2032 (USD Million)
TABLE 185. GCC Non-invasive Prenatal Genetic Testing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 186. GCC Non-invasive Prenatal Genetic Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 187. GCC Non-invasive Prenatal Genetic Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 188. GCC Non-invasive Prenatal Genetic Testing Market Size, by Expanded Panels, 2017-2032 (USD Million)
TABLE 189. GCC Non-invasive Prenatal Genetic Testing Market Size, by High Risk Pregnancies, 2017-2032 (USD Million)
TABLE 190. GCC Non-invasive Prenatal Genetic Testing Market Size, by Routine Screening, 2017-2032 (USD Million)
TABLE 191. European Union Non-invasive Prenatal Genetic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 192. European Union Non-invasive Prenatal Genetic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 193. European Union Non-invasive Prenatal Genetic Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 194. European Union Non-invasive Prenatal Genetic Testing Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 195. European Union Non-invasive Prenatal Genetic Testing Market Size, by Ngs, 2017-2032 (USD Million)
TABLE 196. European Union Non-invasive Prenatal Genetic Testing Market Size, by Testing Approach, 2017-2032 (USD Million)
TABLE 197. European Union Non-invasive Prenatal Genetic Testing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 198. European Union Non-invasive Prenatal Genetic Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 199. European Union Non-invasive Prenatal Genetic Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 200. European Union Non-invasive Prenatal Genetic Testing Market Size, by Expanded Panels, 2017-2032 (USD Million)
TABLE 201. European Union Non-invasive Prenatal Genetic Testing Market Size, by High Risk Pregnancies, 2017-2032 (USD Million)
TABLE 202. European Union Non-invasive Prenatal Genetic Testing Market Size, by Routine Screening, 2017-2032 (USD Million)
TABLE 203. BRICS Non-invasive Prenatal Genetic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 204. BRICS Non-invasive Prenatal Genetic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 205. BRICS Non-invasive Prenatal Genetic Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 206. BRICS Non-invasive Prenatal Genetic Testing Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 207. BRICS Non-invasive Prenatal Genetic Testing Market Size, by Ngs, 2017-2032 (USD Million)
TABLE 208. BRICS Non-invasive Prenatal Genetic Testing Market Size, by Testing Approach, 2017-2032 (USD Million)
TABLE 209. BRICS Non-invasive Prenatal Genetic Testing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 210. BRICS Non-invasive Prenatal Genetic Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. BRICS Non-invasive Prenatal Genetic Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 212. BRICS Non-invasive Prenatal Genetic Testing Market Size, by Expanded Panels, 2017-2032 (USD Million)
TABLE 213. BRICS Non-invasive Prenatal Genetic Testing Market Size, by High Risk Pregnancies, 2017-2032 (USD Million)
TABLE 214. BRICS Non-invasive Prenatal Genetic Testing Market Size, by Routine Screening, 2017-2032 (USD Million)
TABLE 215. G7 Non-invasive Prenatal Genetic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 216. G7 Non-invasive Prenatal Genetic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 217. G7 Non-invasive Prenatal Genetic Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 218. G7 Non-invasive Prenatal Genetic Testing Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 219. G7 Non-invasive Prenatal Genetic Testing Market Size, by Ngs, 2017-2032 (USD Million)
TABLE 220. G7 Non-invasive Prenatal Genetic Testing Market Size, by Testing Approach, 2017-2032 (USD Million)
TABLE 221. G7 Non-invasive Prenatal Genetic Testing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 222. G7 Non-invasive Prenatal Genetic Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. G7 Non-invasive Prenatal Genetic Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 224. G7 Non-invasive Prenatal Genetic Testing Market Size, by Expanded Panels, 2017-2032 (USD Million)
TABLE 225. G7 Non-invasive Prenatal Genetic Testing Market Size, by High Risk Pregnancies, 2017-2032 (USD Million)
TABLE 226. G7 Non-invasive Prenatal Genetic Testing Market Size, by Routine Screening, 2017-2032 (USD Million)
TABLE 227. NATO Non-invasive Prenatal Genetic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 228. NATO Non-invasive Prenatal Genetic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 229. NATO Non-invasive Prenatal Genetic Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 230. NATO Non-invasive Prenatal Genetic Testing Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 231. NATO Non-invasive Prenatal Genetic Testing Market Size, by Ngs, 2017-2032 (USD Million)
TABLE 232. NATO Non-invasive Prenatal Genetic Testing Market Size, by Testing Approach, 2017-2032 (USD Million)
TABLE 233. NATO Non-invasive Prenatal Genetic Testing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 234. NATO Non-invasive Prenatal Genetic Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 235. NATO Non-invasive Prenatal Genetic Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 236. NATO Non-invasive Prenatal Genetic Testing Market Size, by Expanded Panels, 2017-2032 (USD Million)
TABLE 237. NATO Non-invasive Prenatal Genetic Testing Market Size, by High Risk Pregnancies, 2017-2032 (USD Million)
TABLE 238. NATO Non-invasive Prenatal Genetic Testing Market Size, by Routine Screening, 2017-2032 (USD Million)
TABLE 239. Global Non-invasive Prenatal Genetic Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 240. United States Non-invasive Prenatal Genetic Testing Market Size, 2017-2032 (USD Million)
TABLE 241. United States Non-invasive Prenatal Genetic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 242. United States Non-invasive Prenatal Genetic Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 243. United States Non-invasive Prenatal Genetic Testing Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 244. United States Non-invasive Prenatal Genetic Testing Market Size, by Ngs, 2017-2032 (USD Million)
TABLE 245. United States Non-invasive Prenatal Genetic Testing Market Size, by Testing Approach, 2017-2032 (USD Million)
TABLE 246. United States Non-invasive Prenatal Genetic Testing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 247. United States Non-invasive Prenatal Genetic Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 248. United States Non-invasive Prenatal Genetic Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 249. United States Non-invasive Prenatal Genetic Testing Market Size, by Expanded Panels, 2017-2032 (USD Million)
TABLE 250. United States Non-invasive Prenatal Genetic Testing Market Size, by High Risk Pregnancies, 2017-2032 (USD Million)
TABLE 251. United States Non-invasive Prenatal Genetic Testing Market Size, by Routine Screening, 2017-2032 (USD Million)
TABLE 252. Canada Non-invasive Prenatal Genetic Testing Market Size, 2017-2032 (USD Million)
TABLE 253. Canada Non-invasive Prenatal Genetic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 254. Canada Non-invasive Prenatal Genetic Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 255. Canada Non-invasive Prenatal Genetic Testing Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 256. Canada Non-invasive Prenatal Genetic Testing Market Size, by Ngs, 2017-2032 (USD Million)
TABLE 257. Canada Non-invasive Prenatal Genetic Testing Market Size, by Testing Approach, 2017-2032 (USD Million)
TABLE 258. Canada Non-invasive Prenatal Genetic Testing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 259. Canada Non-invasive Prenatal Genetic Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 260. Canada Non-invasive Prenatal Genetic Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 261. Canada Non-invasive Prenatal Genetic Testing Market Size, by Expanded Panels, 2017-2032 (USD Million)
TABLE 262. Canada Non-invasive Prenatal Genetic Testing Market Size, by High Risk Pregnancies, 2017-2032 (USD Million)
TABLE 263. Canada Non-invasive Prenatal Genetic Testing Market Size, by Routine Screening, 2017-2032 (USD Million)
TABLE 264. Mexico Non-invasive Prenatal Genetic Testing Market Size, 2017-2032 (USD Million)
TABLE 265. Mexico Non-invasive Prenatal Genetic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 266. Mexico Non-invasive Prenatal Genetic Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 267. Mexico Non-invasive Prenatal Genetic Testing Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 268. Mexico Non-invasive Prenatal Genetic Testing Market Size, by Ngs, 2017-2032 (USD Million)
TABLE 269. Mexico Non-invasive Prenatal Genetic Testing Market Size, by Testing Approach, 2017-2032 (USD Million)
TABLE 270. Mexico Non-invasive Prenatal Genetic Testing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 271. Mexico Non-invasive Prenatal Genetic Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 272. Mexico Non-invasive Prenatal Genetic Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 273. Mexico Non-invasive Prenatal Genetic Testing Market Size, by Expanded Panels, 2017-2032 (USD Million)
TABLE 274. Mexico Non-invasive Prenatal Genetic Testing Market Size, by High Risk Pregnancies, 2017-2032 (USD Million)
TABLE 275. Mexico Non-invasive Prenatal Genetic Testing Market Size, by Routine Screening, 2017-2032 (USD Million)
TABLE 276. Brazil Non-invasive Prenatal Genetic Testing Market Size, 2017-2032 (USD Million)
TABLE 277. Brazil Non-invasive Prenatal Genetic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 278. Brazil Non-invasive Prenatal Genetic Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 279. Brazil Non-invasive Prenatal Genetic Testing Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 280. Brazil Non-invasive Prenatal Genetic Testing Market Size, by Ngs, 2017-2032 (USD Million)
TABLE 281. Brazil Non-invasive Prenatal Genetic Testing Market Size, by Testing Approach, 2017-2032 (USD Million)
TABLE 282. Brazil Non-invasive Prenatal Genetic Testing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 283. Brazil Non-invasive Prenatal Genetic Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 284. Brazil Non-invasive Prenatal Genetic Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 285. Brazil Non-invasive Prenatal Genetic Testing Market Size, by Expanded Panels, 2017-2032 (USD Million)
TABLE 286. Brazil Non-invasive Prenatal Genetic Testing Market Size, by High Risk Pregnancies, 2017-2032 (USD Million)
TABLE 287. Brazil Non-invasive Prenatal Genetic Testing Market Size, by Routine Screening, 2017-2032 (USD Million)
TABLE 288. United Kingdom Non-invasive Prenatal Genetic Testing Market Size, 2017-2032 (USD Million)
TABLE 289. United Kingdom Non-invasive Prenatal Genetic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 290. United Kingdom Non-invasive Prenatal Genetic Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 291. United Kingdom Non-invasive Prenatal Genetic Testing Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 292. United Kingdom Non-invasive Prenatal Genetic Testing Market Size, by Ngs, 2017-2032 (USD Million)
TABLE 293. United Kingdom Non-invasive Prenatal Genetic Testing Market Size, by Testing Approach, 2017-2032 (USD Million)
TABLE 294. United Kingdom Non-invasive Prenatal Genetic Testing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 295. United Kingdom Non-invasive Prenatal Genetic Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 296. United Kingdom Non-invasive Prenatal Genetic Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 297. United Kingdom Non-invasive Prenatal Genetic Testing Market Size, by Expanded Panels, 2017-2032 (USD Million)
TABLE 298. United Kingdom Non-invasive Prenatal Genetic Testing Market Size, by High Risk Pregnancies, 2017-2032 (USD Million)
TABLE 299. United Kingdom Non-invasive Prenatal Genetic Testing Market Size, by Routine Screening, 2017-2032 (USD Million)
TABLE 300. Germany Non-invasive Prenatal Genetic Testing Market Size, 2017-2032 (USD Million)
TABLE 301. Germany Non-invasive Prenatal Genetic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 302. Germany Non-invasive Prenatal Genetic Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 303. Germany Non-invasive Prenatal Genetic Testing Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 304. Germany Non-invasive Prenatal Genetic Testing Market Size, by Ngs, 2017-2032 (USD Million)
TABLE 305. Germany Non-invasive Prenatal Genetic Testing Market Size, by Testing Approach, 2017-2032 (USD Million)
TABLE 306. Germany Non-invasive Prenatal Genetic Testing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 307. Germany Non-invasive Prenatal Genetic Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 308. Germany Non-invasive Prenatal Genetic Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 309. Germany Non-invasive Prenatal Genetic Testing Market Size, by Expanded Panels, 2017-2032 (USD Million)
TABLE 310. Germany Non-invasive Prenatal Genetic Testing Market Size, by High Risk Pregnancies, 2017-2032 (USD Million)
TABLE 311. Germany Non-invasive Prenatal Genetic Testing Market Size, by Routine Screening, 2017-2032 (USD Million)
TABLE 312. France Non-invasive Prenatal Genetic Testing Market Size, 2017-2032 (USD Million)
TABLE 313. France Non-invasive Prenatal Genetic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 314. France Non-invasive Prenatal Genetic Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 315. France Non-invasive Prenatal Genetic Testing Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 316. France Non-invasive Prenatal Genetic Testing Market Size, by Ngs, 2017-2032 (USD Million)
TABLE 317. France Non-invasive Prenatal Genetic Testing Market Size, by Testing Approach, 2017-2032 (USD Million)
TABLE 318. France Non-invasive Prenatal Genetic Testing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 319. France Non-invasive Prenatal Genetic Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 320. France Non-invasive Prenatal Gene

Companies Mentioned

  • BGI Genomics Co., Ltd.
  • Centogene AG
  • Circle Genetics, Inc.
  • DNA Diagnostics Center, Inc.
  • Fulgent Genetics, Inc.
  • GenPath, Inc.
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings
  • LifeLabs Medical Laboratory Services
  • Medgenome Labs, Inc.
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • PerkinElmer, Inc.
  • Premaitha Health plc
  • Quest Diagnostics Incorporated
  • Roche Diagnostics International Ltd.
  • Sema4, Inc.
  • Trinity Biotech plc

Related Topics

Related Reports

Non-invasive Prenatal Testing Market - Global Forecast 2026-2032 - Product Image

Non-invasive Prenatal Testing Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Non-Invasive Prenatal DNA Testing Service Market - Global Forecast 2026-2032 - Product Image

Non-Invasive Prenatal DNA Testing Service Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Non-Invasive Prenatal Testing Market (By Product, Gestation Period, Pregnancy Risk, Technology, Application, End User, and Region), Key Company Profiles, Market Dynamics, Trends and Recent Developments - Global Forecast to 2032 - Product Image

Non-Invasive Prenatal Testing Market (By Product, Gestation Period, Pregnancy Risk, Technology, Application, End User, and Region), Key Company Profiles, Market Dynamics, Trends and Recent Developments - Global Forecast to 2032

  • Report
  • Global
From
Non-Invasive Prenatal Testing (NIPT) - Global Strategic Business Report - Product Image

Non-Invasive Prenatal Testing (NIPT) - Global Strategic Business Report

  • Report
  • 456 Pages
  • Global
From
Prenatal Screening Market - Strategic Insights and Forecasts (2026-2035) - Product Image

Prenatal Screening Market - Strategic Insights and Forecasts (2026-2035)

  • Report
  • 176 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.